BioXcel Therapeutics (BTAI) Financials

$0.07

$-0.04 (-37.11%)

As on 04-Sep-2026 16:29EDT

Market cap

$2 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

27.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	0.74	0.64	2.27	1.38	0.38	--
Cost of Revenue	0.41	0.16	2.14	1.26	0.02	0.30
Gross Profit	0.34	0.48	0.12	0.12	0.36	-0.30
Operating Expenses	44.96	50.75	67.37	171.90	160.00	106.94
Operating Profit (EBIT)	-44.63	-50.27	-67.25	-171.78	-159.65	-106.94
Other Income	--	--	--	--	2.10	0.04
Profit before Tax	-70.86	-69.90	-59.60	-179.05	-165.76	-106.93
Provision for Tax	--	--	--	0.15	6.09	-0.30
Profit after Tax (Net Income)	-70.86	-69.90	-59.60	-179.05	-165.76	-106.63
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-165.76	-106.93

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-115.46	-95.46	-93.10	-56.51	76.78	221.67
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	7.11	86.45	109.21	102.94	96.18	1.11
Current Liabilities	137.15	53.93	22.23	27.27	32.90	16.67
Total Liabilities	165.95	44.92	38.34	73.70	205.85	239.44

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.10	0.23	0.94	1.56	2.99	2.63
Current Assets	28.70	44.69	37.39	72.14	202.87	236.81
Total Assets	165.95	44.92	38.34	73.70	205.85	239.44
Total Debt*	104.45	109.66	102.95	101.38	94.16	1.40
Net Current Assets	-108.45	-9.24	15.16	44.88	169.97	220.15

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-57.62	-72.03	-155.01	-135.34	-82.15
Cash Flow from Investing Activities	--	--	--	-0.02	-0.14	-0.45
Cash from Financing Activities	--	56.52	36.66	26.52	96.24	102.45
Net Cash Inflow / Outflow	--	--	--	--	-39.24	19.85

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-5.45	-5.73	-19.61	-97.28	-5.91	-60.97
Cash EPS ($)	-2.58	-5.70	-19.51	-97.11	-5.89	-60.80
Adjusted Book Value ($)	-3.69	--	--	--	2.74	126.75
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-4.72	-23.70	-84.21	-4.82	-46.98
Free Cash Flow per Share ($)	--	-4.72	-23.70	-84.23	-4.83	-47.23

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-581.46	-217.82	-165.94	-84.14	-49.43
ROE (%)	--	74.14	79.67	-1,766.94	-111.08	-49.78
ROA (%)	-62.96	-167.91	-106.39	-128.10	-74.45	-46.42
EBIT Margin (%)	-7,228.57	-8,241.90	-1,962.49	-12,010.07	-42,011.73	--
Net Margin (%)	-9,549.87	-10,887.38	-2,630.14	-12,974.86	-6,694.55	-242,340.91
Cash Profit Margin (%)	-0.04	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-14.52	-0.72	0.64	2.68	--	-1.00
EBIT Growth (%)	-53.63	-18.99	73.17	-5.20	-47.33	-29.94
Net Profit Growth (%)	-39.08	-17.28	66.71	-8.02	-55.45	-30.02
EPS Growth (%)	56.99	0.71	0.80	-15.47	0.90	-0.13
Book Value Growth (%)	31.11	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.28	-0.02	-0.03	-3.64	-0.33
Price / Book Value	27.50	-0.20	-0.01	-0.10	7.85	0.16
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.75	-1.92	-1.68	-0.25	-3.20	1.84
Close Price ($)	1.41	1.60	5.98	47.20	343.68	325.28
High Price ($)	8.08	9.26	66.72	546.00	393.12	1,083.84
Low Price ($)	1.01	1.17	4.80	35.68	140.72	299.44
Market Cap ($ Cr)	2.31	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	-1.15	-1.11	-1.79	1.23	0.01
Short term debt to equity ratio	-0.90	-0.26	0.00	-0.01	0.00	0.00
Current Ratio	0.21	0.83	1.68	2.65	6.17	14.21
Quick Ratio	0.21	0.82	1.65	2.57	6.11	14.21
Interest Coverage	-3.11	-3.12	-2.94	-12.45	-19.18	-2,673.38

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	11.05	36.29	5.78	5.14	66.13	--
Asset Turnover	0.01	0.02	0.04	0.01	0.00	--
Receivable days	--	103.54	16.28	42.22	120.78	--
Inventory Days	--	1,560.11	227.54	576.28	18,125.53	--
Payable days	--	34,176.49	2,526.24	3,461.47	136,110.41	5,323.18
Cash Conversion Cycle	--	-32,512.84	-2,282.43	-2,842.97	-117,864.11	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.